Abstract:Gene therapies have been applied to the treatment of cardiovascular disease, but their use is limited by the need to deliver them to the right target. We have employed targeted contrast ultrasound-mediated gene transfection (TCUMGT) via ultrasound-targeted microbubble destruction (UTMD) to transfer therapeutic genes to specific anatomic and pathological targets. Phospholipid microbubbles (MBs) with pcDNA3.1-human vascular endothelial growth factor 165 (pcDNA3.1-hVEGF165) plasmids targeted to P-selectin (MB+P+VEGFp) were created by conjugating monoclonal antibodies against P-selectin to the lipid shell. These microbubbles were divided into four groups: microbubble only (MB), microbubble+P-selectin (MB+P), microbubble+pcDNA3.1-hVEGF165 plasmid (MB+VEGFp), and microbubble+ P-selectin+pcDNA3.1-hVEGF165 plasmid (MB+P+VEGFp). The reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) results showed that the VEGF gene was successfully transfected by TCUMGT and the efficiency is increased with P-selectin targeting moiety. UTMD-mediated delivery of VEGF increased myocardial vascular density and improved cardiac function, and MB+P+VEGFp delivery showed greater improvement than MB+VEGFp. This study drew support from TCUGMT technology and took advantage of targeted ultrasound contrast agent to identify ischemic myocardium, release pcDNA3.1-hVEGF165 recombinant plasmid, and improve the myocardial microenvironment, so promoting the restoration of myocardial function.

Oligonucleotide-directed Site-Specific Mutagenesis for Rectifing Cdna of Vascular Endothelial Growth Factor(vegf)

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Oligonucleotide-directed multi-point site-specific mutagenesis - Five-point site-specific mutagenesis for modifying subtilisin E gene

Isolating the Cdna Fragment Inhibiting Nontargeted Mutagenesis in Vero Cell by Antisense Technology

Site-directed Mutagenesis of Anti-CD3 Single-chain Fv Fragment (scfv)using Two Side Megaprimer PCR Method

Cloning of human vascular endothelial growth factor cDNA and its expression in COS-7 cells

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

Single-round QuikChange PCR for engineering multiple site-directed mutations in plasmid DNA

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

Incorporation of Site Mutations into a Target Gene with an Improved PCR-based Megaprimer Method

A Rapid and Efficient Method for Multiple-Site Mutagenesis with a Modified Overlap Extension PCR

A QuikChange-like method to realize efficient blunt-ended DNA directional cloning and site-directed mutagenesis simultaneously

AN IMPROVED SITE-DIRECTED MUTAGENESIS PROCEDURE AND APPLICATION FOR IDENTIFICATION OF MUTANT CLONES

Prime Editing of Vascular Endothelial Growth Factor Receptor 2 Attenuates Angiogenesis In Vitro

Site-specific insertion of endonuclease recognition sites into amplicons to improve post-PCR analysis sensitivity of gene mutation

High-fidelity Gene Targeting in Embryonic Stem Cells by Using Sequence Replacement Vectors.

Complementary annealing mediated by exonuclease: a method for seamless cloning and conditioning site-directed mutagenesis

Random-Priming In Vitro Recombination: An Effective Tool For Directed Evolution

"Molecular Bypass": The Application of vascular endothelial growth factor to gene therapy of experimental limb ischemia

A high-efficiency method for site-directed mutagenesis of large plasmids based on large DNA fragment amplification and recombinational ligation

Improvement Of Oligonucleotide-Directed Site-Specific Mutagenesis Using Double-Stranded Plasmid DNA